ArticleBMC pulmonary medicine2025
Trends in tuberculosis-related mortality among adults 35-85 years old in the United States, 1999 to 2022: a nationwide analysis.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From decline to rebound: a 25-year Joinpoint analysis of tuberculosis mortality in the United States, 1999-2023.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTuberculosis (TB) is a significant cause of mortality in the United States (US), impairing individual health and causing national financial burden. Although TB-related mortality has declined in recent years, a variety of factors still make TB difficult to prevent, necessitating further analysis of which demographic groups are most impacted by TB.
methodsTrends in TB-related mortality in individuals aged 35 to 85 + years in the US from 1999 to 2022 were analyzed utilizing the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database. Following data collection, age-adjusted mortality rate (AAMR) and average annual percent change (AAPC) in TB-related mortality were examined. Data was further stratified by sex, race, age, region, and locality.
resultsBetween 1999 and 2022, there were 26,600 deaths related to TB in the US. Overall TB-related mortality significantly declined between 1999 and 2022 (AAPC, -3.95%). Males had consistently higher AAMR than females, with 16,741 deaths among males and 9,859 deaths among females. All racial groups, including Asian or Pacific Islander, Black or African American, White, and Hispanic or Latino individuals experienced significant declines in mortality (AAPC, -3.24%, -5.75%, -3.83%, -4.70%, respectively). Asian or Pacific Islander, Black or African American, and Hispanic or Latino patients had consistently higher AAMR than White patients between 1999 and 2022, however. Individuals older than 65 experienced significantly higher AAMR than younger individuals. South and West regions had higher AAMR than Northeast and Midwest regions, with the West and South experiencing the smallest and largest declines in mortality that were statistically significant, respectively (AAPC, -3.04%, -4.66%). TB-related mortality was higher in urban areas, with 20,680 deaths compared to 3,707 deaths in rural areas.
conclusionAlthough TB-related mortality has declined in the US overall, this improvement has not been experienced equally by all demographic groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.